Compare H1B visa sponsorship data between Goldman Sachs and Regeneron Pharmaceuticals. See how they stack up on salary, approval rates, and more.
Key Statistics Comparison
Total H1B Filings
+1647%
14,154
Goldman Sachs
810
Regeneron Pharmaceuticals
Median Salary
$113,200
Goldman Sachs
+19.1%
$140,000
Regeneron Pharmaceuticals
Approval Rate
99.0%
Goldman Sachs
100.0%
Regeneron Pharmaceuticals
Years Sponsoring
18
Goldman Sachs
18
Regeneron Pharmaceuticals
Historical Trends
H1B Filings Over Time
Goldman Sachs
Regeneron Pharmaceuticals
Median Salary Trend
Goldman Sachs
Regeneron Pharmaceuticals
Where & What They Hire
Top H1B Job Categories
Goldman Sachs
Software Developers 131 filings
Financial and Investment Analysts 83 filings
Financial Quantitative Analysts 73 filings
Financial Risk Specialists 72 filings
Business Intelligence Analysts 63 filings
Regeneron Pharmaceuticals
Biochemists and Biophysicists 11 filings
Chemists 9 filings
Molecular and Cellular Biologists 8 filings
Bioinformatics Scientists 5 filings
Regulatory Affairs Managers 4 filings
Top H1B Work Locations
Goldman Sachs
Dallas, TX 249 filings
Salt Lake City, UT 209 filings
New York, NY 169 filings
Jersey City, NJ 14 filings
New York, NY 12 filings
Regeneron Pharmaceuticals
Tarrytown, NY 46 filings
Rensselaer, NY 5 filings
Warren, NJ 3 filings
East Greenbush, NY 2 filings
Cambridge, MA 2 filings
Year-by-Year Breakdown
| Year | Goldman Sachs | Regeneron Pharmaceuticals | ||||
|---|---|---|---|---|---|---|
| Filings | Salary | Approval | Filings | Salary | Approval | |
| FY2025 | 731 | $113,200 | 99.0% | 63 | $140,000 | 100.0% |
| FY2024 | 310 | $145,000 | 100.0% | 26 | $154,196 | 100.0% |
| FY2023 | 186 | $150,000 | 100.0% | 35 | $150,000 | 100.0% |
| FY2022 | 306 | $149,000 | 100.0% | 22 | $139,567 | 100.0% |
| FY2021 | 527 | $125,000 | 100.0% | 8 | $129,024 | 100.0% |
| FY2020 | 249 | $138,000 | 100.0% | 14 | $131,501 | 100.0% |
| FY2019 | 1,726 | $115,000 | 98.7% | 109 | $115,000 | 100.0% |
| FY2018 | 1,779 | $110,000 | 98.7% | 83 | $110,000 | 98.8% |
| FY2017 | 1,085 | $103,600 | 99.0% | 68 | $101,143 | 100.0% |
| FY2016 | 1,086 | $105,050 | 98.2% | 50 | $91,385 | 100.0% |
Showing most recent 10 years of 18 total
Frequently Asked Questions
- Which company pays higher H1B salaries, Goldman Sachs or Regeneron Pharmaceuticals?
- Regeneron Pharmaceuticals pays higher H1B salaries with a median of $140,000 compared to Goldman Sachs's $113,200.
- Which company sponsors more H1B visas, Goldman Sachs or Regeneron Pharmaceuticals?
- Goldman Sachs has sponsored more H1B visas with 14,154 total filings compared to Regeneron Pharmaceuticals's 810.
- How do Goldman Sachs and Regeneron Pharmaceuticals H1B approval rates compare?
- Goldman Sachs has a 99.0% H1B approval rate while Regeneron Pharmaceuticals has 100.0%. Regeneron Pharmaceuticals has a higher approval rate.